Dosimeters Market is segmented By Type (Active/Battery-Powered Dosimeters, Passive/processed Dosimeters, By Usage (Personal Dosimeters, Area Dosimeters, By End-Users (Hospitals, Ambulatory service centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2024-2031
Dosimeters Market Overview
The Dosimeters Market is expected to grow at a CAGR of 6.6% during the forecast period (2024-2031).
Dosimeters are devices used to measure the amount of energy deposited by ionizing radiation. This measurement is used to estimate the effective dose received by the human body through exposure to external ionizing radiation.
Dosimeters Market Summary
|
Metrics |
Details |
|
Market CAGR |
6.6% |
|
Segments Covered |
By Type, By Usage, By Form, By End-Users, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For More Insights Request Free Sample
Dosimeters Market Dynamics
The global market for dosimeters is driven by the increase in the usage of diagnostic scans involving radiation such as X-rays and CT scans along with their rising availability in emerging markets, stricter regulations regarding usage of dosimeters in environments with exposure risk, increase in the number of cancer treatment procedures and the advances in radiation monitoring technology.
It is estimated that some 3.6 billion diagnostic X-ray examinations are performed every year in the world as per the WHO with the number expected to rise as two-thirds of the world’s population still lacks access to them. Studies have shown that medical personnel working with procedures involving radioactivity have significantly higher rates of cancer with one US study showing a twofold increased risk of brain cancer and a significant increase in melanoma and breast cancer rates for technicians working with fluoroscopically guided interventional procedures. In 2015, the joint commission recommended new regulations which required accredited healthcare facilities to record patient exposure for every CT scan. Such regulations are expected to be implemented globally, leading to potentially higher demand for dosimeters. Almost 50% of cancer patients undergo radiotherapy procedures during their treatment as per the Netherlands Cancer Institute. With the number of cancer patients rising around the world, demand for radiotherapy equipment and associated devices such as dosimeters could rise.
The market is restrained by factors such as the high cost of active dosimeters and the need to establish local centers for the servicing of passive dosimeters. Most of the passive dosimeters used in the market are either TLD or OSL dosimeters. These dosimeters need to be collected back by the manufacturers after a certain amount of time to determine exposure and to log regulatory data. This necessitates local presence to ensure timely delivery and servicing and results in high CapEx for the manufacturers.
Dosimeters Market Segmentation Analysis
Based on product the global market for dosimeters is broadly segmented as – By Type, By Usage, and By End-Users.
By Usage, the global market for dosimeters is bifurcated into personal and area dosimeters. Personal dosimeters dominate the market by volume. This is due to the safety regulations requiring the use of personal dosimeters by all individuals with exposure risk. Personal dosimeters are further segmented into Electronic Personal Dosimeters, film badge dosimeters, pen/pocket dosimeters, thermo-luminescent dosimeters, and OSL dosimeters while the area dosimeters are segmented into gas and solid-state dosimeters. The personal dosimeter market is dominated by the TLD and OSL dosimeters due to their low cost, high accuracy, and their reusability despite the need to process them to get results.
By Type, the global market for dosimeters is bifurcated into active/battery-powered and passive/processed dosimeters. The global market for dosimeters is dominated by passive dosimeters due to their lower cost along with higher reliability.
By End-Users, the global market for dosimeters is segmented into hospitals, ambulatory care providers, and specialty clinics. The global market for dosimeters is dominated by hospitals. This is due to the high capital cost required to install the radiotherapy and other machines along with higher reimbursement from Medicaid in the US. The market for dosimeters in ambulatory care is expected to grow faster than in hospitals due to the lower cost of treatment for non-invasive procedures.
Global Dosimeters Market Geographical Share
The Global Dosimeters market is segmented into North America, Europe, Asia Pacific, South America, Middle-East, and Africa.
North America dominates the global market for dosimeters by revenue. This is due to its large number of radiotherapy, CT scanning, and other equipment which when combined with its stringent regulations regarding staff exposure combine to make it the largest market. The market is expected to grow at a moderate rate due to an increase in the proportion of radiotherapy treatment for cancer.
The Asia-Pacific market is expected to be the fastest-growing market due to increasing demand for diagnostic services and cancer care along with improvement in healthcare infrastructure. Japan represents the largest potential market outside the US due to it having the highest number of CT scanners per capita along with a high number of radiotherapy devices.
Dosimeters Market Key Players and Competitive Landscape
Key players in the market are acquiring smaller competitors, forming joint ventures with international partners to expand in newer markets, and launching new product lines for growth. For instance, Landauer has multiple joint ventures in markets such as Japan, Turkey, and Mexico. An example of a new product launch would be the Instadose product line from Mirion Technologies, which provides continuous exposure readings and connects wirelessly to other devices to share data. Due to the relatively small revenues from the market, large pharma companies are acquiring key players to expand their instrumentation portfolios. For instance, in the last five years, Fortive Inc. has acquired two key players – Landauer and Paysafe.
The North American market is a duopoly between Landauer Inc. and Mirion Technologies with regional competition on a very small scale. Due to modest revenue growth in the region, major players are forming joint ventures with partners in the international market and launching new products. The Non-US market for dosimeters is relatively less concentrated with European companies such as IBA dosimetry competing with the U.S based players.
List of key players
Fortive Inc., Mirion Technologies, Polimaster Inc, Radiation Detection Company Inc., Tracerco Limited, IBA Group, Thermo Fisher Scientific, RAYCAN Technology Co. Ltd (Suzhou), ATOMTEX, Sierra Radiation Dosimetry Service Inc.
In March 2019, Thermo Fisher Scientific Launched its new dosimetry monitoring service. The service aims to streamline the management of radiation safety programs in medical, nuclear, and other industries.
On July 20, 2018, IBA announced that it had decided to explore new strategic alternatives for IBA Dosimetry which could include a sale, merger, initial public offering, or retention of the business.
In September 2017, Fortive Corporation announced its acquisition of Landauer Inc for $770 Million. Landauer will become part of Fortive’s Field Solutions platform within its Professional Instrumentation segment.
In July 2016, Mirion Technologies acquired Canberra Industries, a nuclear instrumentation and measurement specialist from AREVA.
Key Takeaways
• The global market for dosimeters is driven by the increase in the usage of diagnostic scans involving radiation such as X-Rays and CT scans along with their rising availability in emerging markets, stricter regulations regarding usage of dosimeters in environments with exposure risk, increase in the number of cancer treatment procedures and the advances in radiation monitoring technology.
• Based on product the global market for dosimeters is broadly segmented as – By Type, By Usage, By Technology, and By End-Users.
• North America dominates the global market for dosimeters by revenue due to its large number of radiotherapy, CT scanning, and other equipment combined with stringent exposure regulations. The Asia-Pacific market is expected to be the fastest-growing market due to increasing demand for diagnostic services and cancer care along with improvement in healthcare infrastructure.
• Key players in the market are acquiring smaller competitors, forming joint ventures with international partners to expand in newer markets, and launching new product lines for growth. Due to the relatively small revenues from the market, large pharma companies are acquiring key players to expand their instrumentation portfolios. The North American market is a duopoly between Landauer Inc. and Mirion Technologies with regional competition on a very small scale. The Non-US market for dosimeters is relatively less concentrated with European companies competing with the U.S based players.
